I2760

(−)-Isoproterenol (+)-bitartrate salt

powder

• Synonym(s): (−)-Isoprenaline (+)-bitartrate salt
• Empirical Formula (Hill Notation): C₁₁H₁₇NO₃ · C₄H₆O₆
• CAS Number: 54750-10-6
• Molecular Weight: 361.34
• Número MDL: MFCD00069361
• ID de substância PubChem: 24277773
• NACRES: NA.77

Properties

• forma: powder
• Nível de qualidade: 200
• cor: white to off-white
• solubilidade: H₂O: ≥50 mg/mL, clear, colorless to faintly yellow
• originador: Sanofi Aventis
• SMILES string: O[C@@H]([C@H](O)C(O)=O)C(O)=O.CC(C)NC[C@H](O)c1ccc(O)c(O)c1
• InChI: 1S/C11H17NO3.C4H6O6/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8;5-1(3(7)8)2(6)4(9)10/h3-5,7,11-15H,6H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m00/s1
• InChI key: LBOPECYONBDFEM-RWALOXMOSA-N
• Gene Information: human ... ADRB1(153) , ADRB2(154) , ADRB3(155)

Description

Aplicação

(−)-Isoproterenol (+)-bitartrate salt has been used:

• as a component in KRH medium for cyclic adenosine monophosphate (cAMP) assay[1]
• to stimulate preadipocytes to study its concentration responsive curve[2]
• to intraperitoneally administer to mice to evaluate whether the multi-dry-electrode plate (MDEP)-sensor system can assess drug responses[3]

Embalagem

100, 500 mg in ampule

1 g in ampule

Ações bioquímicas/fisiológicas

Isoproterenol functions as an ovine pulmonary vein dilator.[4]

β-Adrenoceptor agonist; increases cytosolic cAMP.

Características e benefícios

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Safety Information

• Pictogramas: GHS07
• Palavra indicadora: Warning
• Frases de perigo: H315 - H319 - H335
• Declarações de precaução: P261 - P305 + P351 + P338
• Classificações de perigo: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Código de classe de armazenamento: 13 - Non Combustible Solids
• WGK: WGK 3